Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASM reports first quarter 2025 results

In This Article:

ASM International NV
ASM International NV

Almere, The Netherlands
April 29, 2025, 6 p.m. CET

Solid start of the year, Q1 sales supported by continued AI-related strength

ASM International N.V. (Euronext Amsterdam: ASM) today reports its Q1 2025 results (unaudited).

Financial highlights

€ million

Q1 2024

Q4 2024

Q1 2025

New orders

697.9

731.4

834.2

yoy change % at constant currencies

10%

8%

14%





Revenue

639.0

809.0

839.2

yoy change % at constant currencies

(8%)

27%

26%





Gross profit

337.8

407.2

447.8

Gross profit margin %

52.9 %

50.3 %

53.4 %





Operating result

187.1

222.3

266.2

Operating result margin %

29.3  %

27.5  %

31.7  %





Adjusted operating result 1

191.8

227.0

271.0

Adjusted operating result margin %1

30.0  %

28.1  %

32.3  %





Net earnings (losses)

173.1

225.8

(28.9)

Adjusted net earnings  1

178.9

231.5

191.9

1 Adjusted figures are non-IFRS performance measures.  Refer to Annex 3 for a reconciliation of non-IFRS performance measures.

  • New orders of €834 million in Q1 2025 increased by 14% over the same period last year at constant currency (increased by 20% as reported), supported by strong GAA 2nm orders, and a relatively solid contribution from the Chinese market in the quarter.

  • Revenue of €839 million increased by 26% at constant currencies (increased by 31% as reported) from Q1 of last year, above the midpoint of the guidance (€810-850 million).

  • Gross profit margin increased to 53.4%, up from both Q1 of last year (52.9%) and up from prior quarter (50.3%). The increase compared to prior quarter was driven by a favorable product and customer mix.

  • Adjusted operating result margin of 32.3% is an improvement of 2.3% points compared to the same period last year, and an increase by 4.2% points compared to the previous quarter. This was mainly due to higher gross profit margin and moderated operating expenses (with year-on-year SG&A reducing from 11.4% to 9.1% as a percentage of revenue).

  • Our reported net results included an impairment of €215 million from our stake in ASMPT, triggered by the reduced market valuation in the recent period. There is no cash impact. Following the impairment, and in line with our accounting policy, the changes in the market value of ASMPT will be included in our quarterly net results in case of further decline or until the impairment charge has been reversed.

Comment